Molecular pathology of parathyroid tumors (Q31889854)

4 July 2017

1 reference

title

Molecular pathology of parathyroid tumors (English)

1 reference

4 July 2017

0 references

Carling T

1

1 reference

4 July 2017

1 March 2001

1 reference

Trends in Endocrinology and Metabolism

4 July 2017

1 reference

4 July 2017

12

1 reference

4 July 2017

53-58

1 reference

4 July 2017

2

1 reference

Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Regulation of parathyroid cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Mutations in the calcium-sensing receptor and their clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Vitamin D receptor genotypes in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Vitamin D receptors and hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Vitamin D receptor genotype is associated with cortical bone loss in Japanese patients with primary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Differences in vitamin D receptor genotype and geographical variation in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

A novel cyclin encoded by a bcl1-linked candidate oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Cyclin D1/PRAD1 as a central target in oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Function of a human cyclin gene as an oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Novel Chromosomal Abnormalities Identified by Comparative Genomic Hybridization in Parathyroid Adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Somatic mutation of the MEN1 gene in parathyroid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Analysis of theRAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Comparative genomic hybridization analysis of human parathyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Positional cloning of the gene for multiple endocrine neoplasia-type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Menin, the product of the MEN1 gene, is a nuclear protein

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Familial hyperparathyroidism without multiple endocrine neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2800%2900345-3

7 January 2021

10.1016/S1043-2760(00)00345-3

Identifiers

DOI

1 reference

4 July 2017

1 reference

PubMed ID

11167122